Launched in 2020, CHOSEN develops dermatologist-designed topical formulations and nutraceuticals addressing pigmentation, skin texture, contour and hair aging. It operates a clinic-to-consumer model that integrates a B2B network of dermatologists with a direct-to-consumer platform, and reports insights from over 150,000 consultations. The company offers around 58 SKUs across doctor-led and D2C segments and its products are prescribed in more than 2,000 clinics nationwide. CHOSEN’s online channel serves customers across India, with nearly 95% of digital sales on its own platform and roughly 70% of revenue driven by repeat customers, primarily women aged 30–50. The company is preparing to expand into global skin-of-color markets in Latin America and East Asia and competes with brands such as Avène, Heliocare, Cetaphil, Sebamed, Shiseido and Dr. Sturm.

Total raised

$6M

Funding rounds

2

Latest round

Series A

Latest activity

May 2026